Paving the way for anti-Abeta active immunotherapy
European Pharmaceutical Review
SEPTEMBER 22, 2023
Active immunotherapy through vaccination has a far lower cost than mAb-based therapies, representing an important decrease of economic burden for healthcare systems at a global scale. He then worked as a clinical scientist for a med tech company developing spinal cord stimulation for people living with spinal cord injury.
77 
Let's personalize your content